Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Chromium picolinate + carnitine is a combination dietary supplement containing two active ingredients: chromium picolinate (a highly bioavailable form of the essential mineral chromium) and L-carnitine (an amino acid derivative involved in fatty acid metabolism). Chromium picolinate supports healthy blood sugar levels by enhancing insulin function and improving carbohydrate, fat, and protein metabolism. L-carnitine facilitates the transport of long-chain fatty acids into mitochondria for energy production, supporting fat utilization during exercise and recovery. Clinical studies have shown that this combination can improve body weight, glycemic control, lipid profiles (except HDL cholesterol), mental health parameters, hormonal balance (notably in women with polycystic ovary syndrome), inflammatory markers, antioxidant capacity, as well as upregulate gene expression related to metabolic health[1][2][3]. The product is primarily marketed for metabolic support including weight management and blood sugar regulation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on chromium picolinate + carnitine.